SCHEMBL7048689

SCHEMBL7048689

Cc1cc(C(=O)O)cc(C(C)(C)C)c1OCCN1CCCCC1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
GAA P10253 2/20 0.55
KDM4E B2RXH2 6/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
MAPT P10636 1/20 0.47
CYP2D6 P10635 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HTT P42858 1/20 0.43
PSMB1 P20618 2/20 0.43
PSMB5 P28074 2/20 0.43
PSMB2 P49721 2/20 0.43
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7050856 0.89 MEN1 (0.51) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL9518234 0.77 ALDH1A1 (0.50) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL7792214 0.76 RXRA (0.39) MAPTHTT
SCHEMBL7988768 0.76 MEN1 (0.68) ALDH1A1GAAKDM4ESMN1; SMN2MEN1
SCHEMBL13915098 0.76 KDM4E (0.56) ALDH1A1GAAKDM4ESMN1; SMN2MEN1
Hydrochloric Acid SCHEMBL7056526 0.74 ESR1 (0.68) ALDH1A1MEN1KMT2AMAPTCYP2D6
SCHEMBL9623299 0.74 PLAU (0.45) CYP2D6CYP3A4
SCHEMBL19317250 0.72 KMT2A (0.59) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL7792403 0.72 TNFRSF1A (0.48) ALDH1A1
SCHEMBL11528246 0.71 CHRNA7 (0.47) ALDH1A1KDM4EMEN1KMT2APSMB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0791590-B1 Benzothiophenes, and formulations and methods using same LILLY CO ELI (US) 2003-05-02 EP disclosed
US-6432982-B1 TREATING POST-MENOPAUSAL WOMEN HAVING OSTEOPOROSIS, CARDIOVASCULAR DISORDERS AND ESTROGEN-DEPENDENT CANCER; RESTENOSIS INHIBITION; ENDOMETRIOSIS ELI LILLY AND COMPANY 2002-08-13 US disclosed
WO-1997030985-A1 BENZOTHIOPHENES, AND FORMULATIONS AND METHODS, USING SAME ELI LILLY AND COMPANY (US) 1997-08-28 WO disclosed
EP-0791590-A1 Benzothiophenes, and formulations and methods using same ELI LILLY AND COMPANY (US) 1997-08-27 EP disclosed